Headache Medicine, v.1, n.1, p. 9-11, jan./fev./mar 2010 11
Since migraine with comorbid conditions, including
depression, anxiety, fatigue and fibromyalgia, have
decreased melatonin levels
7, 18
(i.e. a well known internal
synchronizer of the central and peripheral biological
clocks)19, chronobiological features may particularly be
implicated in those patients, a special attention to those
aspects is important in migraine patients.
REFERENCES
1. Peres MF, Sanchez del Rio M, Seabra ML, Tufik S, Abucham J,
Cipolla-Neto J, Silberstein SD, & Zukerman E. Hypothalamic
involvement in chronic migraine. J Neurol Neurosurg Psychiatry.
2001;71:747-51.
2. Dagan Y. Medical chronobiology in psychiatry and neurology.
CNS Spectr. 2001; 6:462.
3. Turek FW, Dugovic C, & Zee PC. Current understanding of the
circadian clock and the clinical implications for neurological
disorders. Arch Neurol. 2001; 58:1781-7.
4. Tanuri FC, de Lima E, Peres MF, Cabral FR, da Graca Naffah-
Mazzacoratti M, Cavalheiro EA, Cipolla-Neto J, Zukerman E,
Amado D. Melatonin treatment decreases c-fos expression in a
headache model induced by capsaicin. J Headache Pain. 2009;
10:105-10.
5. Peres MF, Zukerman E, da Cunha Tanuri F, Moreira FR, & Cipolla-
Neto J. Melatonin, 3 mg, is effective for migraine prevention.
Neurology. 2004; 63:757.
6. Peres MF, Siow HC, Rozen TD. Hemicrania continua with aura.
Cephalalgia. 2002; 22: 246-8.
7. Masruha MR, Lin J, de Souza Vieira DS, Minett TS, Cipolla-Neto
J, Zukerman E, Vilanova LC, Peres MF. Urinary 6-
sulphatoxymelatonin levels are depressed in chronic migraine
and several comorbidities. Headache. 2009.
8. Masruha MR, de Souza Vieira DS, Minett TS, Cipolla-Neto J,
Zukerman E, Vilanova LC, Peres MF. Low urinary 6-
sulphatoxymelatonin concentrations in acute migraine. J
Headache Pain. 2008; 9: 221-4.
9. Peres MF, Masruha MR, Zukerman E, Moreira-Filho CA,
Cavalheiro EA. Potential therapeutic use of melatonin in migraine
and other headache disorders. Expert Opin Investig Drugs.
2006;15: 367-75.
10. Peres MF. Melatonin, the pineal gland and their implications for
headache disorders. Cephalalgia. 2005; 25: 403-11.
11. Peres MF, Zukerman E, Porto PP, Brandt RA. Headaches and
pineal cyst: a (more than) coincidental relationship? Headache.
2004;44: 929-30.
12. Peres MF, Rozen TD. Melatonin in the preventive treatment of
chronic cluster headache. Cephalalgia. 2001; 21:993-5.
13. Peres MF, Stiles MA, Oshinsky M, Rozen TD. Remitting form of
hemicrania continua with seasonal pattern. Headache. 2001;
41: 592-4.
14. Peres MF, Seabra ML, Zukerman E, Tufik S. Cluster headache
and melatonin. Lancet. 2000; 355:147.
15. Murialdo G, Fonzi S, Costelli P, Solinas GP, Parodi C, Marabini
S, Fanciullacci M, Polleri A. Urinary melatonin excretion
throughout the ovarian cycle in menstrually related migraine.
Cephalalgia. 1994;14:205-9.
16. Claustrat B, Loisy C, Brun J, Beorchia S, Arnaud JL, Chazot G.
Nocturnal plasma melatonin levels in migraine: a preliminary
report. Headache. 1989;29:242-5.
17. Nagtegaal JE, Laurant MW, Kerkhof GA, Smits MG, van der
Meer YG, Coenen AM. Effects of melatonin on the quality of life
in patients with delayed sleep phase syndrome. J Psychosom
Res. 2000;48:45-50.
18. Peres MF, Zukerman E, Young WB, Silberstein SD. Fatigue in
chronic migraine patients. Cephalalgia. 2002;22:720-4.
19. Afeche SC, Amaral FC, Villela DCM, Abrahão MV, Peres R,
Cipolla-Neto J. Melatonn and the pineal gland. In: Romano E,
De Luca S, Eds. New Research on Neurosecretory System. Nova
Biomedical Books, New York, 2008, pp. 151-177.
Endereço para correspondência
DrDr
DrDr
Dr
. Mario F. Mario F
. Mario F. Mario F
. Mario F
ernando Pernando P
ernando Pernando P
ernando P
rieto Prieto P
rieto Prieto P
rieto P
ereseres
ereseres
eres
Al. Joaquim Eugenio de Lima, 881cj 708
São Paulo,SP, Brazil
http://cefaleias.com.br/
marioperes@cefaleias.com.br
CHRONOBIOLOGICAL FEATURES IN EPISODIC AND CHRONIC MIGRAINE